Doximity Inc. reported its fiscal first-quarter results for 2026, surpassing revenue and earnings expectations. The company posted revenues of $145.9 million, a 15% increase year-over-year, exceeding the consensus estimate of $139 million. Earnings per share came in at $0.36, beating the estimated $0.31. Operating cash flow rose 51% to $62.1 million, while free cash flow increased 52% to $60.1 million. Net income was reported at $53.3 million. Doximity's AI suite experienced fivefold growth year-over-year, with over 630,000 prescribers using its workflow tools. For the second quarter of fiscal 2026, the company guided revenues between $157 million and $158 million and adjusted EBITDA between $87 million and $88 million. Full-year fiscal 2026 guidance projects revenues of $628 million to $636 million and adjusted EBITDA of $341 million to $349 million. Following the earnings release, several analysts raised their price targets on Doximity shares, including Raymond James and Needham, both increasing targets to $75, and Canaccord raising its target to $59. Separately, DigitalOcean Holdings Inc. announced plans to offer $500 million in convertible senior notes due 2030 through a private placement to qualified institutional buyers. Similarly, Upstart Holdings Inc. disclosed a proposed private offering of $500 million in convertible senior notes due 2032, subject to market conditions.